Search Results - Georg Karpel‐Massler

Refine Results
  1. 1
    CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide

    CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous... by Richard E. Kast, Georg Karpel‐Massler, Marc‐Eric Halatsch

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Therapeutic Inhibition of the Epidermal Growth Factor Receptor in High-Grade Gliomas: Where Do We Stand?

    Therapeutic Inhibition of the Epidermal Growth Factor Receptor in High-Grade Gliomas: Where Do We Stand? by Georg Karpel‐Massler, Ursula Schmidt, Andreas Unterberg, Marc‐Eric Halatsch

    Published 2009
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Novel IDH1-Targeted Glioma Therapies

    Novel IDH1-Targeted Glioma Therapies by Georg Karpel‐Massler, Trang Nguyen, Enyuan Shang, Markus D. Siegelin

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Impaired Cerebral Vasomotor Activity in Spontaneous Intracerebral Hemorrhage

    Impaired Cerebral Vasomotor Activity in Spontaneous Intracerebral Hemorrhage by Jennifer Diedler, M. Sýkora, André Rupp, Sven Poli, Georg Karpel‐Massler, Oliver Sakowitz, Thorsten Steiner

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Targeting intrinsic apoptosis and other forms of cell death by BH3-mimetics in glioblastoma

    Targeting intrinsic apoptosis and other forms of cell death by BH3-mimetics in glioblastoma by Georg Karpel‐Massler, Chiaki Tsuge Ishida, Yiru Zhang, Marc‐Eric Halatsch, Mike‐Andrew Westhoff, Markus D. Siegelin

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    BH3-mimetics and BET-inhibitors elicit enhanced lethality in malignant glioma

    BH3-mimetics and BET-inhibitors elicit enhanced lethality in malignant glioma by Chiaki Tsuge Ishida, Elena Bianchetti, Chang Shu, Marc‐Eric Halatsch, Mike‐Andrew Westhoff, Georg Karpel‐Massler, Markus D. Siegelin

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin

    Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin by Richard E. Kast, Quentin A. Hill, Didier Wion, Håkan Mellstedt, Daniele Focosi, Georg Karpel‐Massler, Tim Heiland, Marc‐Eric Halatsch

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    Inhibition of HDAC1/2 Along with TRAP1 Causes Synthetic Lethality in Glioblastoma Model Systems

    Inhibition of HDAC1/2 Along with TRAP1 Causes Synthetic Lethality in Glioblastoma Model Systems by Trang Nguyen, Yiru Zhang, Enyuan Shang, Chang Shu, Catarina M. Quinzii, Mike‐Andrew Westhoff, Georg Karpel‐Massler, Markus D. Siegelin

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    TIC10/ONC201 synergizes with Bcl-2/Bcl-xL inhibition in glioblastoma by suppression of Mcl-1 and its binding partners <i>in vitro</i> and <i>in vivo</i>

    TIC10/ONC201 synergizes with Bcl-2/Bcl-xL inhibition in glioblastoma by suppression of Mcl-1 and its binding partners <i>in vitro</i> and <i>in vivo</i> by Georg Karpel‐Massler, Maïmouna Bâ, Chang Shu, Marc‐Eric Halatsch, Mike‐Andrew Westhoff, Jeffrey N. Bruce, Peter Canoll, Markus D. Siegelin

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Metabolic reprogramming of glioblastoma cells by L-asparaginase sensitizes for apoptosis <i>in vitro</i> and <i>in vivo</i>

    Metabolic reprogramming of glioblastoma cells by L-asparaginase sensitizes for apoptosis <i>in vitro</i> and <i>in vivo</i> by Georg Karpel‐Massler, Doruntina Ramani, Chang Shu, Marc‐Eric Halatsch, Mike‐Andrew Westhoff, Jeffrey N. Bruce, Peter Canoll, Markus D. Siegelin

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Temozolomide and Other Alkylating Agents in Glioblastoma Therapy

    Temozolomide and Other Alkylating Agents in Glioblastoma Therapy by Hannah A. Strobel, Tim Baisch, Rahel Fitzel, Katharina Schilberg, Markus D. Siegelin, Georg Karpel‐Massler, Klaus‐Michael Debatin, Mike‐Andrew Westhoff

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    RIST: A potent new combination therapy for glioblastoma

    RIST: A potent new combination therapy for glioblastoma by Lisa Nonnenmacher, Mike‐Andrew Westhoff, Simone Fulda, Georg Karpel‐Massler, Marc‐Eric Halatsch, Jens Engelke, Thomas Simmet, Selim Corbacioglu, Klaus‐Michael Debatin

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy

    A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy by Mike‐Andrew Westhoff, Georg Karpel‐Massler, Oliver Brühl, Stefanie Enzenmüller, Katia La Ferla-Brühl, Markus D. Siegelin, Lisa Nonnenmacher, Klaus‐Michael Debatin

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Inhibition of deubiquitinases primes glioblastoma cells to apoptosis <i>in vitro</i> and <i>in vivo</i>

    Inhibition of deubiquitinases primes glioblastoma cells to apoptosis <i>in vitro</i> and <i>in vivo</i> by Georg Karpel‐Massler, Matei A. Banu, Chang Shu, Marc‐Eric Halatsch, Mike‐Andrew Westhoff, Jeffrey N. Bruce, Peter Canoll, Markus D. Siegelin

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    The Alcatraz‐Strategy: a roadmap to break the connectivity barrier in malignant brain tumours

    The Alcatraz‐Strategy: a roadmap to break the connectivity barrier in malignant brain tumours by Matthias Schneider, Anna‐Laura Potthoff, Georg Karpel‐Massler, Patrick Schuss, Markus D. Siegelin, Klaus‐Michael Debatin, Hugues Duffau, Hartmut Vatter, Ulrich Herrlinger, Mike‐Andrew Westhoff

    Published 2024
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  16. 16
    A Synthetic Cell-Penetrating Dominant-Negative ATF5 Peptide Exerts Anticancer Activity against a Broad Spectrum of Treatment-Resistant Cancers

    A Synthetic Cell-Penetrating Dominant-Negative ATF5 Peptide Exerts Anticancer Activity against a Broad Spectrum of Treatment-Resistant Cancers by Georg Karpel‐Massler, Basil A. Horst, Chang Shu, Lily Chau, Takashi Tsujiuchi, Jeffrey N. Bruce, Peter Canoll, Lloyd A. Greene, James M. Angelastro, Markus D. Siegelin

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Combined Inhibition of HER1/EGFR and RAC1 Results in a Synergistic Antiproliferative Effect on Established and Primary Cultured Human Glioblastoma Cells

    Combined Inhibition of HER1/EGFR and RAC1 Results in a Synergistic Antiproliferative Effect on Established and Primary Cultured Human Glioblastoma Cells by Georg Karpel‐Massler, Mike‐Andrew Westhoff, Shaoxia Zhou, Lisa Nonnenmacher, Annika Dwucet, Richard E. Kast, Max G. Bachem, Christian Rainer Wirtz, Klaus‐Michael Debatin, Marc‐Eric Halatsch

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Noninvasive Ultra Low Intensity Light Photodynamic Treatment of Glioblastoma with Drug Augmentation: LoGlo PDT Regimen

    Noninvasive Ultra Low Intensity Light Photodynamic Treatment of Glioblastoma with Drug Augmentation: LoGlo PDT Regimen by Richard E. Kast, Anton Kast, Jürgen Arnhold, Felix Capanni, Laura N. Milla Sanabria, Nicolas Bader, Bruno Marques Vieira, Alex Alfieri, Georg Karpel‐Massler, Erasmo Barros da Silva

    Published 2024
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    The effects of PI3K-mediated signalling on glioblastoma cell behaviour

    The effects of PI3K-mediated signalling on glioblastoma cell behaviour by Julia Langhans, Lukas Schneele, Nancy Trenkler, Hélène von Bandemer, Lisa Nonnenmacher, Georg Karpel‐Massler, Markus D. Siegelin, Shaoxia Zhou, Marc‐Eric Halatsch, Klaus‐Michael Debatin, Mike‐Andrew Westhoff

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Induction of Synthetic Lethality by Activation of Mitochondrial ClpP and Inhibition of HDAC1/2 in Glioblastoma

    Induction of Synthetic Lethality by Activation of Mitochondrial ClpP and Inhibition of HDAC1/2 in Glioblastoma by Trang Nguyen, Enyuan Shang, Salveena Schiffgens, Consuelo Torrini, Chang Shu, Hasan O. Akman, Varun V. Prabhu, Joshua E. Allen, Mike‐Andrew Westhoff, Georg Karpel‐Massler, Markus D. Siegelin

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: